Informação sobre produto
- 1-[(3R)-6,8-Difluoro-3,4-dihydro-2H-1-benzopyran-3-yl]-1,3-dihydro-5-[2-[(phenylmethyl)amino]ethyl]-2H-imidazole-2-thione
- 2H-Imidazole-2-thione, 1-[(3R)-6,8-difluoro-3,4-dihydro-2H-1-benzopyran-3-yl]-1,3-dihydro-5-[2-[(phenylmethyl)amino]ethyl]-
- (R)-5-(2-(Benzylamino)ethyl)-1-(6,8-difluorochroman-3-yl)-1H-imidazole-2(3H)-thione
Zamicastat is a drug that is used in the treatment of vascular dementia, including multi-infarct dementia and Alzheimer's disease. It has been shown to reduce systolic pressure and improve clinical response in patients with congestive heart failure. Zamicastat inhibits the production of dopamine β-hydroxylase, which is an enzyme that catalyzes the conversion of dopamine to norepinephrine. It also inhibits the production of chemoattractant protein, an inflammatory mediator. This drug is being investigated as a possible diagnostic agent for cardiac hypertrophy and sildenafil for the treatment of erectile dysfunction.
Propriedades químicas
Consulta técnica sobre: 3D-FTB02880 Zamicastat
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
